Making complex biology scalable just got a $100K boost for 3D Bio-Tissues ltd. The biotechnology company, powered by BSF plc, announced new funding to advance its work in developing macromolecular crowders-simple media additives designed to mimic natural physiological environments. These solutions aim to accelerate cell growth and significantly reduce operational costs for partners in cell-based therapies and cellular agriculture.
3D Bio-Tissues specializes in optimizing how cells interact with their environment, offering products like CityMix™ for cultivated meat, CytoBoost™ for biopharmaceutical science, and CytoBoost™ REVIVE for post-thaw cell recovery. The company's technology helps move complex biological processes from lab-scale success to industrial-scale reality.















